ATLANTA, May 22, 2018 /PRNewswire/ -- Alimera Sciences (NASDAQ: ALIM), a leader in the commercialization and developmentof prescription ophthalmic pharmaceuticals, today announced that CEO Dan Myers will be presenting at the 8th annual LD Micro Invitational Conference taking place June 4-6, 2018 at
The Company's presentation will take place on June 5th at 8:30 AM and a webcast will be available on the Company's website at www.alimerasciences.com.
About Alimera Sciences, Inc.www.alimerasciences.comAlimera, founded in June 2003, is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in our aging populations. Alimera's commitment to retina specialists and their patients is manifest in Alimera's product portfolio. For more information, please visit www.alimerasciences.com.
For press inquiries:Katie Brazelfor Alimera Sciences email@example.com
For investor inquiries:CG Capitalfor Alimera Sciences877firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/alimera-sciences-to-present-at-the-8th-annual-ld-micro-invitational-conference-300652295.html
SOURCE Alimera Sciences, Inc.
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All